New Search

If you are not happy with the results below please do another search

25 search results for:

1

Exploring JCA Timelines: Opportunities and Challenges for Pharma and Biotech

/0 Comments/in
Exploring JCA Timelines: Opportunities and Challenges for Pharma and Biotech In the evolving landscape of EU healthcare, the introduction of Joint Clinical Assessments (JCA) as part of the new Health Technology Assessment (HTA) regulations signifies a pivotal shift. These assessments are redefining Pharma and Biotech companies' approach to product evaluation and approval, presenting both significant [...]
3

Preparing for EU Joint Clinical Assessment 2025

/0 Comments/in
Preparing for EU Joint Clinical Assessment 2025: Leveraging Gen AI Technology to Navigate the New Era in Health Technology Assessment   As we edge closer to 2025, the pharmaceutical landscape in Europe is poised for a transformative change with the implementation of the new EU Health Technology Assessment (HTA) regulations. This pivotal move, aimed at harmonizing [...]
4

Pharma WhatsApp communications with physicians

/0 Comments/in
Solutions WhatsApp Business API for Pharma & Physician Communications While pharmaceutical organizations and the healthcare sector have been becoming increasingly more digitalized, it was the COVID-19 pandemic that accelerated the need for much faster adoption and agility, including digital communication channels between pharma organizations and healthcare professionals. The healthcare sector, together with hospitals, physicians and [...]
5

Insights from Generative AI Implementations: 4 Focus Areas

/0 Comments/in
Solutions 9 Months In: Insights from Generative AI Implementations in Pharma & Biotech - Our 4 Focus Areas In an age of rapid technological breakthroughs, the usage of artificial intelligence has progressed beyond mere buzzwords to become an essential component of company operations. A subclass of AI known as generative AI has enormous promise, allowing [...]
6

Bespoke ChatGPT for compliant, impactful patient & healthcare professionals engagement

/0 Comments/in
Solutions Bespoke ChatGPT for compliant, impactful patient & healthcare professionals engagement Contact us now for a live-demo In today's rapidly evolving healthcare landscape, effective communication between pharmaceutical companies, patients, healthcare professionals (HCPs), and nurses is paramount. To bridge the gap and deliver exceptional customer experiences, a groundbreaking solution has emerged: Custom ChatGPT using Pharma-owned & [...]
7

Blog

Exploring JCA Timelines: Opportunities and Challenges for Pharma and Biotech0 Comments/10. April 2024Read more https://ffi-ventures.com/wp-content/uploads/2024/04/image-blog-1-scaled.jpg 1707 2560 adminffi https://staging.ffi-ventures.com/wp-content/uploads/2018/03/cropped-ffi_logo_fav_380-300x300.gif adminffi2024-04-10 15:21:022024-04-18 09:50:49Exploring JCA Timelines: Opportunities and Challenges for Pharma and BiotechSwiss Rare Disease Day 2024: Insights from the ProRaris Event at the Inselspital Bern0 Comments/10. April 2024Read more https://ffi-ventures.com/wp-content/uploads/2024/03/post-web-raredisease-2.png 1920 1920 adminffi https://staging.ffi-ventures.com/wp-content/uploads/2018/03/cropped-ffi_logo_fav_380-300x300.gif adminffi2024-04-10 15:19:162024-04-18 [...]
8

Home

STRATEGYInsightful Strategies for Growth, Innovation and Excellence in Healthcare Solutions EXECUTIONExcellence in Execution for Impact, Efficiency and Results Solutions PRODUCT SOLUTIONSInnovative Solutions to Drive Superior Customer Experience Solutions PreviousNext123 1 Strategy Guided by profound insights into patient, healthcare provider (HCP) and payer needs combined with deep knowledge of complex market dynamics, our strategies result in [...]
9

Swiss Rare Disease Day 2024: Insights from the ProRaris Event at the Inselspital Bern

Swiss Rare Disease Day 2024: Insights from the ProRaris Event at the Inselspital Bern On March 2nd, 2024, the event "Internationaler Tag der seltenen Krankeiten in der Schweiz" took place at the Auditorium Ettore Rossi, Inselspital Bern, to commemorate the 14th International Rare Disease Day in Switzerland. Organized by ProRaris, the symposium gathered around 150 [...]
10

Preparing for EU Joint Clinical Assessment 2025

Preparing for EU Joint Clinical Assessment 2025: Leveraging Gen AI Technology to Navigate the New Era in Health Technology Assessment   As we edge closer to 2025, the pharmaceutical landscape in Europe is poised for a transformative change with the implementation of the new EU Health Technology Assessment (HTA) regulations. This pivotal move, aimed at harmonizing [...]